Injectable Drug Delivery News

  1. Meissa Vaccines Enters Into cGMP Manufacturing Agreement For Pediatric RSV Vaccine Candidate For Phase 2 Clinical Trials 6/28/2023

    Meissa Vaccines (“Meissa”), a clinical-stage biotechnology company developing vaccines to prevent viral respiratory infections, today announced it has entered into a manufacturing agreement with Exothera S.A. (“Exothera”), a Univercells company and full-service Contract Research Development and Manufacturing Organization (CRDMO) delivering customized process development and GMP manufacturing services for vaccines, viral vectors and nucleic acids.

  2. Stevanato Group Presents Vertiva, A Versatile On-Body Delivery System Platform For A Wide Range Of Injectable Therapies And For Large Delivery Volumes (Up To 100mL) 6/12/2023

    Stevanato Group S.p.A. a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology and life sciences industries, unveiled today Vertiva, the latest release of its patented On-Body Delivery System (OBDS), intended to be able to switch between basal and bolus injections and to be suitable for a wide range of subcutaneous therapies.

  3. Corning And SGD Pharma Announce Joint Venture To Open New Glass Tubing Facility And Expand Access To Corning Velocity Vial Technology In India 6/8/2023

    Corning Incorporated and SGD Pharma today announced a joint venture that includes the opening of a new glass tubing facility to expand pharmaceutical manufacturing in India and allows SGD Pharma to adopt Corning’s Velocity Vial technology platform.

  4. Viridian Therapeutics Announces Partnership With Drug Delivery Innovator Enable Injections 5/8/2023

    Viridian Therapeutics, Inc., a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced a new partnership with Enable Injections, a company developing and manufacturing the enFuse® innovative wearable drug delivery system for volumes of up to 25mL.

  5. Moderna And Novocol Pharma Announce Fill-Finish Agreement For Canadian-Made mRNA Vaccines 5/4/2023

    Moderna, Inc. (NASDAQ: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a long-term agreement with Ontario-based Novocol Pharma, a leading sterile injectable contract development and manufacturing organization (CDMO), to perform aseptic fill-finish, labelling and packaging of mRNA respiratory vaccines expected to be produced in Canada.

  6. SHL Medical And MoonLake Immunotherapeutics Collaborate To Develop Sonelokimab Autoinjector 5/3/2023

    SHL Medical, a world-leading provider of advanced drug delivery solutions, announced that it has signed a collaboration agreement with MoonLake Immunotherapeutics, a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, to develop an autoinjector for clinical and potential commercial supply of MoonLake's Nanobody® sonelokimab based on SHL Medical's Molly® autoinjector technology.

  7. FDA Approval For High Potency Fill Line 4/19/2023

    Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce that the United States Food and Drug Administration (FDA) has approved the company's high potency vial line to manufacture a commercial product.

  8. Berkshire Sterile Adds Non-Destructive Weight Checks To Their Low-Loss Fill Line 4/12/2023

    Berkshire Sterile Manufacturing (BSM), a fill finish CDMO located in Lee, MA, recently purchased a high precision load cell to perform non-destructive weight checks as part of their low loss fill process. The load cell is a Mettler Toledo WMF Series balance featuring unique capabilities to auto adjust for the environment and take highly accurate measurements in turbulent or highly unstable settings.

  9. Bridgewest Group Launches NovaCina, New Sterile Injectable CDMO 4/4/2023

    Global private investment firm, Bridgewest Group, recognized for developing innovative companies in life sciences, software, and deep tech, launches new Contract Development and Manufacturing Organization (CDMO) focused on sterile injectable drug products. This follows the recent announcement on the acquisition of the Perth sterile injectable manufacturing plant from Pfizer.

  10. Scaling Up Capacity, Eitan Medical Opens New Manufacturing Facility Bolstered by Semi-Automated Production Lines 3/22/2023

    Eitan Medical, a global leader in advanced infusion therapy and drug delivery solutions across the care continuum, announced today the opening of its new manufacturing facility at the company’s headquarters. On-site manufacturing will support Eitan Medical’s production scale of its Pharmaceutical Solutions division.